NOTV Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -22.62%, SMA50 -45.32%, SMA200 -80.3%). The stock’s 14-day RSI is 26.3 (weak momentum), while the ATR of 0.04 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -93.15% below its high and over 7.53% above its low.

Inotiv, Inc. generated EPS of -$2.02 over the past year. Five-year average earnings growth is -37.4%. The latest quarter delivered EPS of -$0.94. The next quarter is forecast at -$0.64. Next year's EPS is expected at $102.45. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 2 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $5.00 to $3.00. The high target offers 6150.0% upside. The low target suggests 3650.0% downside. The mean target is $4.00. This offers 4900.0% upside. Inotiv, Inc. earnings surprise history is a mixed track record. The quarter that ended May 11, 2026, missed forecasts by 48.03%. The prior quarter beat by 12.85%. Over the last six quarters, Apple has recorded several small beats. These include -25.0% in May 07, 2025.

Inotiv, Inc. has 34.35 million shares outstanding. The public float is 31.21 million shares, elevated short interest at 7.01% of float. This equals 2.26 million shares. The short ratio is 5.56 days. Institutional investors hold 15.32% of the float. Insiders own 8.64%. Leasure Robert Jr. holds 1.26 million shares, Sagartz John E has 735.70 thousand shares and Landman David has 176.85 thousand shares. Over the past six months, insider transactions show net selling. They sold 21.82 thousand shares across 3 transactions.

Inotiv, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$1.96. This means the shares are trading below this model’s fair value.

Inotiv, Inc. (NASDAQ:NOTV) closed at $0.08 USD, gaining $0.04 (121.94%) from the previous close of $0.04. The stock is currently mid-range between its 52-week high and low $0.02 and $2.44. With a market capitalization of about $2.79 million, Inotiv, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~4.08). Key stats such as the average daily volume over the past year has been around 19.82 million shares, in line with its 52-week average. Headquartered in West Lafayette, IN, Inotiv, Inc. operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Robert W. Leasure, the company employs approximately 2,027 people and listed since November 25, 1997. Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally.

Inotiv, Inc. trades at a P/E ratio of -0.03, slightly below the S&P 500 average, with a price-to-sales ratio of 0.01 and a price-to-book ratio of 0.04 suggesting the stock is closer to book value. The P/FCF stands at -0.2, also above market averages.

Inotiv, Inc. (NASDAQ:NOTV) shares are flat -3.54% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Inotiv, Inc. trading at a premium to the broader market with a P/E of -0.03. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $16.10, suggesting 20050.19% upside. Our AI forecast model points to short-term weakness (-37.42% over two weeks), a medium-term fall (-62.45% over three months), and a longer-term loss (-87.48% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Inotiv, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -37.42%, with price expected at $0.05 by June 24, 2026, within a range of $0.00 to $0.11 3-Month Outlook: Projected fall of -62.45%, reaching $0.03 by September 08, 2026, with a range of $0.00 to $0.12. 1-Year Outlook: Projected loss of -87.48%, with price at $0.01 by June 10, 2027, within a range of $0.00 to $0.00.